José Alexandre Carneiro BorgesDeclared Swiss shareholdings
José Alexandre Carneiro Borges: 0 Swiss companies with a declared holding. Latest filing: 07.08.2014.
- Estimated value (CHF)
- —
- Swiss companies held
- 0
- Largest position
- —
- 12-month trend
- Not determinable
- 0 rate rises · 0 rate falls
- Latest filing
- 07.08.2014
- Active since 2013
Declared Swiss portfolio
Latest declared rate per company
No active declared position.
How to read these figures?
Rates come from the 3 official filings published by SIX Exchange Regulation. A filing is only required when a threshold is crossed (3, 5, 10, 15, 20, 25, 33⅓, 50, 66⅔%): the actual position may have changed since.
Estimated value = shares held per the latest filing × latest CHF closing price. It is an indicative order of magnitude: the position may have changed without a new threshold being crossed, and holdings without a share count or a CHF price are not valued. Each company's mini-chart traces the successive declared rates.
This profile shows only what the declarant published. No external data is added to it.
Group structure
Shareholding disclosures are often filed jointly by several entities of the same group. The registry links them together: "Controls" lists the group entities declared alongside this shareholder, "Controlled by" the head entities. The figure is the number of joint disclosures, followed by the date of the most recent one.
Show group structure20 controls
Controls
Group entities linked to this shareholder in joint disclosures.
- Bluefin II Fundo de Investimento Multimercado3 · 07.08.2014
- Breckenridge Lane Investments, L.P3 · 07.08.2014
- Fundo de Investimento de Ações Tarpon CFJ3 · 07.08.2014
- Fundo de Investimento em Ações Sul América Governança I3 · 07.08.2014
- Stanhore Trading International S.A3 · 07.08.2014
- Sul América Fundo de Investimento em Ações Luz3 · 07.08.2014
- Tokenhouse Fund, LLC3 · 07.08.2014
- TP Partners Fund, L.P3 · 07.08.2014
- TP Partners Public Equities Fund. L.P3 · 07.08.2014
- Wahoo Atlanticus LLC3 · 07.08.2014
- FFB 1 Fundo de Investimento em Ações3 · 07.08.2014
- Fundo de Investimento de Ações Santa Rita3 · 07.08.2014
- Clube de Investimento Tarpon2 · 28.12.2013
- Matrinxã Funda de Investimento Multimercado2 · 28.12.2013
- Fundo de Investimento de Ações Cinco Cinco2 · 28.12.2013
- Tarpon Institucional Fundo de Investimento em Ações2 · 28.12.2013
- TF Fund, LLC1 · 07.08.2014
- Tarpon CSHG Master FIA1 · 07.08.2014
- Longfield Road Investments, LP1 · 07.08.2014
- Marylebone Fund, LP1 · 07.08.2014
This mapping reflects observed disclosures; it does not necessarily indicate permanent legal control.
Disclosure behaviour
Upward and downward threshold crossings show direction, without measuring daily trades below legal thresholds.
90 days · Upward crossings
0
visible history: 2
90 days · Downward crossings
0
visible history: 0
Nature of disclosed positions
Derivatives, sale positions or lending may indicate a more complex strategy than a long equity holding.
Latest shareholding disclosures
Avolta AG
José Alexandre Carneiro Borges · Group of shareholders
Avolta AG
José Alexandre Carneiro Borges · Group of shareholders
Avolta AG
José Alexandre Carneiro Borges · Group of shareholders
insider24.ch
Follow José Alexandre Carneiro Borges’s disclosures
Find new disclosures in your watchlist. With Pro, receive email and Telegram alerts for your chosen companies.
Need more? Discover the Pro plan
Common questions
Which Swiss companies are in José Alexandre Carneiro Borges’s disclosed portfolio?
No active holding identified in available disclosures.
What is José Alexandre Carneiro Borges’s latest disclosure?
The latest available disclosure was published on 07.08.2014 and concerns Avolta AG. Threshold disclosures do not describe every purchase or sale.
Explore further
Recent insider purchases
What are insiders doing at companies disclosed by this shareholder?
All purchases this weekInsider barometer
Compare insider purchases and sales across the Swiss stock exchange over 30 days.
View the Swiss barometerThese signals are not investment advice.